Earnings Scheduled For March 8, 2023
Companies Reporting Before The Bell
• Daktronics (NASDAQ:DAKT) is expected to report quarterly earnings at $0.00 per share on revenue of $164.68 million.
ChromaDex Shares Promising Findings From A Clinical Study Showcasing Combined Metabolic Activators, Featuring Nicotinamide Riboside, Improved Cognitive Functions In Alzheimer’s Disease Patients
This first-of-its-kind human clinical study in AD patients showcased CMA supplementation significantly improved cognitive function and associated biomarkers
ChromaDex Corp. (NASDAQ:CDXC), a global bioscience company
Why Party City Holdco Shares Tumbled Over 40%; Here Are 98 Biggest Movers From Yesterday
Gainers
Unique Fabricating, Inc. (NYSE: UFAB) jumped 56.3% to close at $0.8205 on Tuesday. Unique Fabricating posted a Q3 loss of $0.90 per share after the closing bell on Tuesday.
Why TaskUs Shares Are Trading Higher By 37%? Here Are 77 Stocks Moving In Tuesday’s Mid-Day Session
Gainers
IceCure Medical Ltd (NASDAQ: ICCM) shares jumped 39.4% to $1.4529 after the company announced a payment assignment from the Centers for Medicare & Medicaid Services for the ProSense breast cancer cryoablation procedures.
ChromaDex Announces Findings From Study On Safety And Tolerability Of Nicotinamide Riboside In Heart Failure With Reduced Ejection Fraction
This is the first study to investigate the safety and tolerability of NR in a randomized, placebo-controlled trial of patients with heart failure, marking a milestone for future clinical research
LOS ANGELES--(BUSINESS
This Analyst Cuts ChromaDex’s Price Target On Revised Growth Trajectory
Earlier this month, ChromaDex Corp (NASDAQ:CDXC) released Q2 earnings, indicating high single-digit revenue growth for FY22, driven by its global e-commerce…